Dr. Robert Stanley Taylor , MD
Dermatology - MOHS-Micrographic Surgery • Longview, TX
3535 N Fourth St Ste 400
Longview, TX 756050036
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Robert Taylor is listed in NPPES under Dermatology - MOHS-Micrographic Surgery.
-
NPI assigned on March 18, 2006; this date does not establish years in practice.
-
Published CMS data list 384 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17311 — Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks: 169 service units.
- 17312 — Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks: 48 service units.
- 12032 — Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm: 40 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 10 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 47 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Doxycycline Hyclate — 47 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 90% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: 2,049. Middle half: 1,241 to 3,279.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 466 in 2020 to 384 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3535 N Fourth St Ste 400
Longview, TX 756050036
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Wallis Dermatology Associates Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Texas Medical Branch At Galveston
1985
What Public CMS Data Show
Dermatology - MOHS-Micrographic Surgery: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
189 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $158,932 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $125,102 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
47 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$381 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $565.06 across 23 records.
By nature of payment
- Food and Beverage: $565.06 across 23 records.
Reporting-company totals (3 largest of 7)
- Sanofi and Genzyme US Companies: $378.99 across 15 records.
- Incyte Corporation: $38.88 across 2 records.
- UCB, Inc.: $38.61 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
41 years (graduated 1985)
CMS Doctors and Clinicians data list 1985 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Taylor has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Taylor as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Longview and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 90% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: 2,049. Middle half: 1,241 to 3,279.
Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 85% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: $562,347. Middle half: $289,356 to $764,203.
Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 85% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: $438,976. Middle half: $212,612 to $591,747.
Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 108 clinicians with data). Median for this group: 377. Middle half: 173 to 741.
Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 90% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 108 clinicians with data). Median for this group: $5,017. Middle half: $2,110 to $14,930.
Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Dermatology - MOHS-Micrographic Surgery with a practice address in Longview, TX (122 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 18% from 466 in 2020 to 384 in 2024.
- 2020: 466
- 2021: 509
- 2022: 491
- 2023: 297
- 2024: 384
-
Medicare-allowed amount
Medicare-allowed amount decreased 16% from $190,221 in 2020 to $158,932 in 2024.
- 2020: $190,221
- 2021: $199,590
- 2022: $205,865
- 2023: $123,257
- 2024: $158,932
-
Paid by Medicare
Paid by Medicare decreased 17% from $151,354 in 2020 to $125,102 in 2024.
- 2020: $151,354
- 2021: $158,173
- 2022: $163,186
- 2023: $95,696
- 2024: $125,102
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 25% from 63 in 2020 to 47 in 2024.
- 2020: 63
- 2021: 34
- 2022: 46
- 2023: 39
- 2024: 47
-
30-day fills
30-day fills decreased 25% from 63 in 2020 to 47 in 2024.
- 2020: 63
- 2021: 34
- 2022: 46
- 2023: 39
- 2024: 47
-
Part D drug cost
Part D drug cost went from $239 in 2020 to $381 in 2024.
- 2020: $239
- 2021: $138
- 2022: $269
- 2023: $408
- 2024: $381
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $29.33 in 2021 to $565.06 in 2025.
- 2021: $29.33
- 2022: $48.67
- 2023: $54.20
- 2024: $370.34
- 2025: $565.06
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $565.06.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.68 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.34 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.11 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.70 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.54 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.27 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.26 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.87 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.50 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $25.31 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $24.84 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $24.48 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.88 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $21.11 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $20.74 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $20.58 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $18.14 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $18.03 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $17.80 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $17.71 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $16.33 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17311
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
|
169 | 139 | $1570.00 | $561.23 |
|
17312
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
|
48 | 34 | $960.00 | $390.41 |
|
12032
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
|
40 | 38 | $730.00 | $244.96 |
|
12052
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
|
38 | 35 | $740.00 | $153.74 |
|
12042
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm
|
22 | 21 | $725.00 | $173.80 |
|
13121
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
|
16 | 16 | $1020.00 | $232.84 |
|
14060
Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less
|
14 | 14 | $1850.00 | $729.96 |
|
17313
Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
|
14 | 11 | $1475.00 | $607.09 |
|
11402
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
12 | 12 | $405.00 | $81.94 |
|
13132
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
|
11 | 11 | $1145.00 | $222.95 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Doxycycline Hyclate | Doxycycline Hyclate | 47 | 408 | $381.31 | 41 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-09-30NUCC Taxonomy Code: 207ND0101X
The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20100525000752
TX
2163551466
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Wallis Dermatology Associates Pllc
1900 S Washington Ave, Marshall, TX 756706845
Phone: 9035037330
Wallis Dermatology Associates Pllc
3535 N 4th St, Longview, TX 756050036
Phone: 9037573881
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Practice Registered Nurse - Certified Nurse Practitioner
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Nurse Practitioner
Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050036 (Tel: 9037573881)
Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050036 (Tel: 9037573881)
NPI status registered as active in NPPES database
Registered at 5323 HARRY HINES BLVD, DALLAS, TX 753907208 (Tel: 2146452400)
Registered at PO BOX 845347, DALLAS, TX 752845347 (Tel: 2146452400)
Recorded as ROBERT TAYLOR, MD
Dermatology (license number reported to NPPES: TX H0877)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
3535 N Fourth St Ste 400
Longview, TX 756050036
Phone: 9037573881